HealthLynked (HLYKD) AI Stock Analysis

• Market Cap: $4.17M
• Dividend Yield: N/A
• Average Volume (3M): 2.63K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.23
• Revenue Growth: -36.61%
• EPS Growth: -10.84%
• Country: US
• Employees: 20
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): N/A
• Shares Outstanding: 2,819,472
• 10 Day Avg. Volume: 4,542
• 30 Day Avg. Volume: 2,625
• PEG Ratio: >-0.01
• Price to Book (P/B): -1.93
• Price to Sales (P/S): 2.00
• P/FCF Ratio: -1.72
• Enterprise Value/Market Cap: 2.66
• Enterprise Value/Revenue: 4.31
• Enterprise Value/Gross Profit: 4.44
• Enterprise Value/Ebitda: -3.24
• 1Y Price Target: $2.50
• Price Target Upside: 2.04% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 41 Neutral
• Price Target: $2.50 ▲(2.04% Upside)

The overall stock score of 41 reflects significant financial distress, as evidenced by declining revenues, high net losses, and negative equity. Technical indicators also show bearish momentum, and the negative P/E ratio highlights valuation concerns. These factors collectively indicate a challenging outlook for HealthLynked.

HealthLynked Business Overview & Revenue Model

Company Description

HealthLynked Corp. operates a cloud-based patient information network and record archiving system in the United States. It operates through four divisions: Health Services, Digital HealthCare, Accountable Care Organization/Managed Service Organization (ACO/MSO), and Medical Distribution. The Health Services division provides obstetrical and gynecological medical services to patients; functional medicine focusing on neurodegenerative diseases, such as Alzheimer's, Parkinson's, and multiple sclerosis; and Bridging the Gap Physical Therapy, a physical therapy practice to speed patients' recovery and manage pain without pain medication or surgery. The Digital HealthCare division operates HealthLynked Network, which enables patients and doctors to keep track of medical information via internet in a cloud-based system; and enables patients to enter a detailed online personal medical history, including past surgical history, medications, allergies, and family medical history. This segment also offers online scheduling function for patients to book appointments with providers. The ACO/MSO division operates an ACO and MSO that assists physician practices in providing care to patients via the Medicare Shared Savings Program; and offers contracted consulting services to healthcare providers and other ACOs. The Medical Distribution Division operates as a virtual distributor of discounted medical supplies selling to consumers and medical practice. The company was incorporated in 2014 and is headquartered in Naples, Florida.

How the Company Makes Money

HealthLynked generates revenue through multiple streams, primarily derived from subscription fees for its health record management services and telehealth platform. The company charges healthcare providers for access to its software solutions, which facilitate patient data management and telemedicine consultations. Additionally, HealthLynked may earn revenue from partnerships with healthcare institutions that utilize its platform to enhance their service offerings. The company also explores opportunities in data analytics and health information exchange, potentially monetizing aggregated health data while ensuring patient privacy. Overall, its diverse revenue model is supported by an increasing demand for digital health solutions and the ongoing transition toward value-based care in the healthcare industry.

HealthLynked Financial Statement Overview

Summary

HealthLynked faces significant financial challenges, with declining revenues, high net losses, and negative equity. The company's reliance on external financing and persistent negative cash flows indicate financial distress. Urgent corrective measures are needed to stabilize the company's finances and improve its long-term viability.

Income Statement

The income statement shows declining revenues from $9,197,992 in 2021 to $3,008,361 in 2024, indicating significant revenue contraction. Gross profit margins remained relatively high, but the company experienced substantial net losses, increasing from -$1,012,203 in 2023 to -$6,131,479 in 2024. The EBIT and EBITDA margins are also negative, reflecting ongoing operational challenges and negative earnings before interest and taxes.

Balance Sheet

The balance sheet reveals a negative stockholders' equity of -$3,129,209 in 2024, down from $804,730 in 2023, highlighting financial instability. The debt-to-equity ratio is effectively unmeasurable due to negative equity, suggesting high leverage. The equity ratio is negative, indicating liabilities exceed assets, signaling potential insolvency risks.

Cash Flow

Cash flow analysis shows consistently negative free cash flow, with -$3,494,122 in 2024. Operating cash flow is negative, indicating the company is not generating sufficient cash from operations to cover its expenses. There is a slight improvement in financing cash flow, suggesting reliance on external financing to sustain operations.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.58M	3.01M	5.72M	5.86M	9.20M	6.13M
Gross Profit	2.50M	2.91M	2.35M	5.40M	6.18M	4.97M
EBITDA	-3.43M	-4.36M	-2.75M	-7.05M	-9.85M	-4.73M
Net Income	-4.96M	-6.13M	-1.01M	-8.82M	-10.41M	-6.15M
Balance Sheet
Total Assets	1.85M	2.22M	4.28M	4.58M	10.69M	8.03M
Cash, Cash Equivalents and Short-Term Investments	20.20K	76.24K	247.22K	61.89K	3.29M	162.18K
Total Debt	5.48M	997.85K	1.97M	1.28M	978.19K	2.89M
Total Liabilities	6.60M	5.35M	3.48M	4.27M	3.49M	6.68M
Stockholders Equity	-4.75M	-3.13M	804.73K	314.45K	7.20M	1.35M
Cash Flow
Free Cash Flow	-2.63M	-3.50M	-4.15M	-4.39M	-3.79M	-2.14M
Operating Cash Flow	-2.63M	-3.49M	-4.14M	-4.36M	-3.77M	-2.12M
Investing Cash Flow	425.00K	422.40K	3.51M	-544.75K	-341.36K	1.81M
Financing Cash Flow	2.05M	2.90M	824.09K	1.68M	7.24M	356.80K

HealthLynked Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2.45
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HLYKD, the sentiment is Positive. The current price of 2.45 is above the 20-day moving average (MA) of 2.35, below the 50-day MA of 2.70, and below the 200-day MA of 3.16, indicating a neutral trend. The MACD of -0.23 indicates Positive momentum. The RSI at 51.97 is Neutral, neither overbought nor oversold. The STOCH value of 32.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HLYKD.

HealthLynked Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
AMS	50 Neutral	15.69M	-6.74	-9.97%	―	26.61%	-156.30%
CCEL	50 Neutral	35.53M	-192.31	1.10%	8.89%	1.10%	98.13%
PIII	46 Neutral	62.24M	-0.15	-178.90%	―	4.20%	-54.16%
CCM	44 Neutral	24.53M	-0.52	13.52%	―	-29.82%	-2.57%
HLYKD	41 Neutral	$4.17M	―		―	-36.61%	-10.84%
MODVQ	40 Underperform	3.88M	-0.02	523.15%	―	-0.70%	-2.38%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%